{"id":"https://openalex.org/W2139794866","doi":"https://doi.org/10.1046/j.1360-0443.2002.00081.x","title":"The Benzodiazepine Withdrawal Symptom Questionnaire: psychometric evaluation during a discontinuation program in depressed chronic benzodiazepine users in general practice","display_name":"The Benzodiazepine Withdrawal Symptom Questionnaire: psychometric evaluation during a discontinuation program in depressed chronic benzodiazepine users in general practice","alternate_titles":[],"publication_year":2002,"publication_date":"2002-03-01","ids":{"openalex":"https://openalex.org/W2139794866","doi":"https://doi.org/10.1046/j.1360-0443.2002.00081.x","mag":"2139794866","pmid":"https://pubmed.ncbi.nlm.nih.gov/11964110"},"language":"en","primary_location":{"id":"doi:10.1046/j.1360-0443.2002.00081.x","doi":"https://doi.org/10.1046/j.1360-0443.2002.00081.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1360-0443.2002.00081.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139794866"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021980974","display_name":"Jaap E. Couv\u00e9e","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156610","display_name":"GlaxoSmithKline (Netherlands)","ror":"https://ror.org/05atcw115","country_code":"NL","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210156610"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jaap E. Couv\u00e9e","raw_affiliation_strings":["Medical Department, GlaxoSmithKline, Zeist, The Netherlands. jaap.e.couvee@gsk.com","Medical Department, GlaxoSmithKline, Zeist and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, GlaxoSmithKline, Zeist, The Netherlands. jaap.e.couvee@gsk.com","institution_ids":["https://openalex.org/I4210156610"]},{"raw_affiliation_string":"Medical Department, GlaxoSmithKline, Zeist and","institution_ids":["https://openalex.org/I4210156610"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032227732","display_name":"Frans G. Zitman","orcid":"https://orcid.org/0000-0003-1987-988X","observed_orcids":["https://orcid.org/0000-0003-1987-988X"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frans G. Zitman","raw_affiliation_strings":["Department of Psychiatry, Leids Universitair Medisch Centrum, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Leids Universitair Medisch Centrum, Leiden, the Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021980974"],"corresponding_institution_ids":["https://openalex.org/I4210156610"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":2.1551,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.8531262,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"97","issue":"3","first_page":"337","last_page":"345"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.13019999861717224,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.03440000116825104,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal-syndrome","display_name":"benzodiazepine withdrawal syndrome","score":0.9589999914169312},{"id":"https://openalex.org/keywords/benzodiazepine-discontinuation","display_name":"benzodiazepine discontinuation","score":0.9120000004768372},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6179999709129333},{"id":"https://openalex.org/keywords/chronic-benzodiazepine-use","display_name":"chronic benzodiazepine use","score":0.8650000095367432},{"id":"https://openalex.org/keywords/psychometric-properties","display_name":"psychometric properties","score":0.656000018119812},{"id":"https://openalex.org/keywords/construct-validity","display_name":"construct validity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/reliability-statistics","display_name":"reliability statistics","score":0.5960000157356262},{"id":"https://openalex.org/keywords/test-retest-correlation","display_name":"test-retest correlation","score":0.6880000233650208},{"id":"https://openalex.org/keywords/factor-structure","display_name":"factor structure","score":0.7620000243186951},{"id":"https://openalex.org/keywords/benzodiazepine-tapering","display_name":"benzodiazepine tapering","score":0.6700000166893005},{"id":"https://openalex.org/keywords/general-practice","display_name":"general practice","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.8936461210250854},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8844442367553711},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6439188122749329},{"id":"https://openalex.org/C2776922375","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Withdrawal syndrome","level":2,"score":0.5414211750030518},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.5391858220100403},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5139769911766052},{"id":"https://openalex.org/C198999979","wikidata":"https://www.wikidata.org/wiki/Q5159115","display_name":"Concurrent validity","level":4,"score":0.45900365710258484},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4576496183872223},{"id":"https://openalex.org/C171606756","wikidata":"https://www.wikidata.org/wiki/Q506132","display_name":"Psychometrics","level":2,"score":0.42245811223983765},{"id":"https://openalex.org/C3018868096","wikidata":"https://www.wikidata.org/wiki/Q2693233","display_name":"Internal consistency","level":3,"score":0.3192867934703827},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30839648842811584},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.21966621279716492},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1744907796382904},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D005194","descriptor_name":"Family Practice","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011594","descriptor_name":"Psychometrics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012678","descriptor_name":"Sensation Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012678","descriptor_name":"Sensation Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025341","descriptor_name":"Principal Component Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1360-0443.2002.00081.x","doi":"https://doi.org/10.1046/j.1360-0443.2002.00081.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1360-0443.2002.00081.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},{"id":"pmid:11964110","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11964110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction (Abingdon, England)","raw_type":"Evaluation Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W203242492","https://openalex.org/W572198986","https://openalex.org/W1974695911","https://openalex.org/W1978296118","https://openalex.org/W1987366798","https://openalex.org/W1990397462","https://openalex.org/W1998935547","https://openalex.org/W2006697438","https://openalex.org/W2058713081","https://openalex.org/W2065430497","https://openalex.org/W2080072810","https://openalex.org/W2082111758","https://openalex.org/W2092731872","https://openalex.org/W2095818922","https://openalex.org/W2168595696","https://openalex.org/W4213353653"],"related_works":["https://openalex.org/W2095818922","https://openalex.org/W3137118245","https://openalex.org/W2058713081","https://openalex.org/W7133508298","https://openalex.org/W2144509364","https://openalex.org/W1981933738","https://openalex.org/W1990397462","https://openalex.org/W2794163361","https://openalex.org/W2103482466","https://openalex.org/W2101881744"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,89],"Benzodiazepine":[2],"Withdrawal":[3],"Symptom":[4],"Questionnaire":[5],"(BWSQ,":[6],"Tyrer":[7],"et":[8],"al.":[9],"1990)":[10],"has":[11],"been":[12],"developed":[13],"to":[14,138],"measure":[15,139],"distinct":[16],"features":[17],"of":[18,26,76,96,114,122,165],"the":[19,35,56,64,77,93,111,125,136],"benzodiazepine":[20,50,142],"withdrawal":[21,80,143,159],"syndrome.":[22],"However,":[23],"psychometric":[24],"evaluations":[25],"this":[27],"questionnaire":[28],"are":[29],"scarce.":[30],"AIMS,":[31],"SETTING:":[32],"To":[33],"evaluate":[34],"BWSQ":[36,78,137],"during":[37,55,72,79,110,141,158],"a":[38,145],"discontinuation":[39,129],"program":[40,57],"carried":[41],"out":[42],"by":[43],"general":[44],"practitioners":[45],"in":[46,124,144],"230":[47],"depressed":[48],"chronic":[49],"users.":[51],"FINDINGS:":[52],"Reliability":[53],"coefficients":[54],"were":[58,67],"between":[59,68,82],"0.84":[60],"and":[61,63,70,84,98,105],"0.88":[62,71],"test-retest":[65],"correlations":[66],"0.75":[69],"withdrawal.":[73],"Mean":[74],"scores":[75,109,157],"differentiated":[81],"completers":[83],"failures":[85],"(p":[86,130],"=":[87,131],"0.036).":[88],"factor":[90],"structure":[91],"underlying":[92],"items":[94],"consisted":[95],"perceptual":[97],"sensory":[99],"disturbances,":[100],"dysphoric":[101],"mood,":[102],"muscular":[103],"pain":[104],"memory":[106],"loss.":[107],"Low":[108,156],"last":[112],"phase":[113],"tapering":[115],"off":[116],"predicted":[117],"no,":[118],"or":[119],"limited,":[120],"use":[121,164],"benzodiazepines":[123],"first":[126],"years":[127],"following":[128],"0.003).":[132],"CONCLUSIONS:":[133],"We":[134],"found":[135],"symptoms":[140],"reliable":[146],"way.":[147],"Our":[148],"findings":[149],"indicate":[150],"some":[151],"construct":[152],"validity":[153],"for":[154],"BWSQ.":[155],"predict":[160],"more":[161],"limited":[162],"future":[163],"benzodiazepines.":[166]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139794866","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
